Q3 2024 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2024-11-14 · accession 0001172661-24-004870
$888.7M
Reported value
66
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $105.8M | 11.9% | 1,450,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $88.1M | 9.91% | 530,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $46.1M | 5.19% | 550,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $39.6M | 4.46% | 750,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $35.0M | 3.94% | 1,050,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $33.8M | 3.80% | 160,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $27.0M | 3.04% | 300,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $26.8M | 3.02% | 290,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $26.6M | 2.99% | 275,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $23.0M | 2.59% | 200,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $23.0M | 2.58% | 275,000 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $22.7M | 2.56% | 200,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $22.1M | 2.49% | 500,000 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $18.6M | 2.10% | 120,000 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $16.5M | 1.86% | 400,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $15.9M | 1.79% | 350,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $15.8M | 1.78% | 250,000 | CALL | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $15.3M | 1.72% | 300,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $13.4M | 1.50% | 1,275,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $13.3M | 1.50% | 500,000 | CALL | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $12.3M | 1.39% | 375,000 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $12.1M | 1.37% | 110,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $11.6M | 1.31% | 200,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $11.1M | 1.25% | 220,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $10.2M | 1.15% | 300,000 | CALL | SOLE |
| 358029106 | FMS | FRESENIUS MEDICAL CARE AG | $9.6M | 1.08% | 450,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $9.3M | 1.05% | 135,000 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $9.1M | 1.02% | 175,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $8.9M | 1.00% | 10,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $8.0M | 0.91% | 120,000 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $8.0M | 0.89% | 400,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $7.5M | 0.84% | 1,800,000 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $7.4M | 0.83% | 30,000 | Common | SOLE |
| 10950A106 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $7.3M | 0.83% | 500,000 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $7.0M | 0.79% | 150,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $6.9M | 0.77% | 25,000 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $6.8M | 0.77% | 800,000 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $6.6M | 0.74% | 350,000 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $6.4M | 0.72% | 150,000 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $5.9M | 0.67% | 50,000 | Common | SOLE |
| 219798105 | QDEL | QUIDELORTHO CORP | $5.7M | 0.64% | 125,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $5.7M | 0.64% | 250,000 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $5.7M | 0.64% | 200,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $5.4M | 0.61% | 80,000 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $4.7M | 0.53% | 20,000 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $4.6M | 0.52% | 2,375,000 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORP | $4.5M | 0.51% | 100,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $4.5M | 0.51% | 200,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $4.3M | 0.49% | 356,000 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $4.1M | 0.46% | 1,000,000 | Common | SOLE |
| 714046109 | RVTY | REVVITY INC | $3.8M | 0.43% | 30,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $3.7M | 0.42% | 500,000 | Common | SOLE |
| 62855J104 | MYGN | MYRIAD GENETICS INC | $3.4M | 0.39% | 125,000 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $3.4M | 0.38% | 975,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $3.4M | 0.38% | 300,000 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $2.9M | 0.33% | 70,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $2.5M | 0.28% | 300,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $2.2M | 0.25% | 275,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $2.1M | 0.24% | 450,000 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $2.1M | 0.23% | 100,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $2.0M | 0.22% | 400,000 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $1.9M | 0.21% | 20,000 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $1.9M | 0.21% | 50,000 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $1.5M | 0.17% | 200,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $1.2M | 0.14% | 250,000 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $978,000 | 0.11% | 200,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.